Carregant...
Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study
PURPOSE: During treatment with tyrosine kinase inhibitors, such as sunitinib, patients experience treatment and/or disease-related symptoms. Although application of patient-reported outcome measures (PROMs) enhances early recognition of symptoms, early clinical trials are focused on symptom severity...
Guardat en:
| Publicat a: | Support Care Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6018583/ https://ncbi.nlm.nih.gov/pubmed/29464389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-018-4075-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|